CID 71597013

Lwewimrqvrmvmsrlra

Structural Information

Molecular Formula
C105H173N33O23S3
SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC(C)C)N
InChI
InChI=1S/C105H173N33O23S3/c1-15-57(10)83(138-96(155)77(49-60-51-121-65-27-19-17-25-62(60)65)134-89(148)71(33-35-80(141)142)127-95(154)76(132-84(143)63(106)46-53(2)3)48-59-50-120-64-26-18-16-24-61(59)64)100(159)131-72(36-43-162-12)90(149)123-67(29-21-40-117-103(110)111)86(145)126-70(32-34-79(107)140)92(151)136-81(55(6)7)98(157)129-69(31-23-42-119-105(114)115)87(146)128-74(38-45-164-14)93(152)137-82(56(8)9)99(158)130-73(37-44-163-13)91(150)135-78(52-139)97(156)125-68(30-22-41-118-104(112)113)88(147)133-75(47-54(4)5)94(153)124-66(28-20-39-116-102(108)109)85(144)122-58(11)101(160)161/h16-19,24-27,50-51,53-58,63,66-78,81-83,120-121,139H,15,20-23,28-49,52,106H2,1-14H3,(H2,107,140)(H,122,144)(H,123,149)(H,124,153)(H,125,156)(H,126,145)(H,127,154)(H,128,146)(H,129,157)(H,130,158)(H,131,159)(H,132,143)(H,133,147)(H,134,148)(H,135,150)(H,136,151)(H,137,152)(H,138,155)(H,141,142)(H,160,161)(H4,108,109,116)(H4,110,111,117)(H4,112,113,118)(H4,114,115,119)/t57-,58-,63-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,81-,82-,83-/m0/s1
InChIKey
ASKSDLRLUXEOOR-SUFRFZPQSA-N
Compound name
(4S)-5-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-1-carboxyethyl]amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

897
Patents

2360.2544 Da
Monoisotopic Mass

-2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2361.2617 474.4
[M+Na]+ 2383.2436 454.4
[M-H]- 2359.2471 474.2
[M+NH4]+ 2378.2882 461.9
[M+K]+ 2399.2176 455.4
[M+H-H2O]+ 2343.2517 447.9
[M+HCOO]- 2405.2526 455.1
[M+CH3COO]- 2419.2683 450.4
[M+Na-2H]- 2381.2291 483.0
[M]+ 2360.2539 419.1
[M]- 2360.2549 419.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.